Bryan Dunnivant
Director/Board Member presso Intradigm Corp.
Profilo
Mr. Bryan Dunnivant, CFA MBA, is Managing Director & Oxford Investment Fellow at Oxford Financial Group Ltd.
Prior to joining Oxford in 2015, he was Investment Director, Pension and Benefits, at Eli Lilly and Company.
In that role he had investment management and oversight responsibility for approximately $13 billion in assets.
His responsibilities included due diligence, manager selection and monitoring, performance evaluation and risk management.
He has over 25 years of leadership experience in the United States and Europe.
He holds a BS in Chemical Engineering from the University of Illinois.
He also holds an MBA from Butler University.
He is a CFA charter holder.
Posizioni attive di Bryan Dunnivant
| Società | Posizione | Inizio |
|---|---|---|
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Director/Board Member | 01/01/2008 |
Precedenti posizioni note di Bryan Dunnivant
| Società | Posizione | Fine |
|---|---|---|
HemaQuest Pharmaceuticals, Inc.
 HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA. | Chairman | 28/07/2010 |
| ELI LILLY AND COMPANY | Chief Operating Officer | 31/12/2004 |
| PROTAGONIST THERAPEUTICS, INC. | Director/Board Member | - |
Protagonist Pty Ltd.
 Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Director/Board Member | - |
Fast Track Systems, Inc.
 Fast Track Systems, Inc. Packaged SoftwareTechnology Services Fast Track Systems, Inc. provides clinical trial software and professional services to pharmaceutical and biotechnology companies. It offers data-driven systems approach to expediting clinical trial design, setup and execution. The company was founded in 1991 and is headquartered in Conshohocken, PA. | Director/Board Member | - |
Formazione di Bryan Dunnivant
| Butler University | Masters Business Admin |
| University of Illinois | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
Intradigm Corp.
Intradigm Corp. Pharmaceuticals: MajorHealth Technology Intradigm Corp. develops drugs and therapies. Its RNAi therapeutic platform comprised of proprietary delivery technologies, potent siRNA sequences and innovative siRNA structural features. The company was founded by Puthupparampil Scaria, Martin C. Woodle, Wei-Wu He and Patrick Y. Lu in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
Protagonist Pty Ltd.
Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Health Technology |
Fast Track Systems, Inc.
Fast Track Systems, Inc. Packaged SoftwareTechnology Services Fast Track Systems, Inc. provides clinical trial software and professional services to pharmaceutical and biotechnology companies. It offers data-driven systems approach to expediting clinical trial design, setup and execution. The company was founded in 1991 and is headquartered in Conshohocken, PA. | Technology Services |
LV Management Group, LLC
 LV Management Group, LLC Investment ManagersFinance Lilly Ventures Management Group LLC (Lilly ventures) is a venture capital firm, a subsidiary of Eli Lilly & Co. founded in 2001 by S.Edward Torres and Ron Laufer. The firm is headquartered in Indianapolis,Indiana. | Finance |
HemaQuest Pharmaceuticals, Inc.
HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology HemaQuest Pharmaceuticals, Inc. develops small molecule therapeutics. Its products include hydroxyurea, a therapeutic agent for the treatment of underlying pathology of sickle cell anemia and for the treatments of beta thalassemia, sickle cell anemia, neutropenia, and various hematological disorders. The company was founded by Ronald J. Berenson, Douglas V. Faller, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos and Robert Williams in October 2007 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Bryan Dunnivant
